About this Webinar:
This session, ‘Using Artificial Intelligence (AI) to support Quantitative Digital Pathology in R&D’, was live on Wednesday 17th November 2021. You can re-watch the full webinar including the Q&A above.
Presented by OracleBio’s Chief Scientific Officer, Lorcan Sherry, it covered:
- Using AI Deep Learning to improve image analysis accuracy and turn-around time in a pre-clinical tumor IHC study
- Integrating clinical pathologist input in development and validation of a Deep Learning Tissue Classifier App
- Advantages of implementing Deep Learning for tissue segmentation and cell detection in multiplex IF studies
- and more…
Lorcan Sherry
Chief Scientific Officer
As co-founder and Chief Scientific Officer at OracleBio, Lorcan has helped establish the company as a market leader within its field, supporting the digital pathology programmes of major Pharma and Biotech companies around the globe.
Day to day, Lorcan oversees a team of image analysis scientists and pathologists responsible for the execution of Client image analysis R&D studies, while further driving the adoption of innovative techniques and processes to improve the quality and efficiency of our services.
More from OracleBio:
Quantitative spatial phenotyping of the tumor microenvironment in NSCLC tissue microarray cores using 6-plex multiplex imaging technology and AI-powered phenotyping analysis
ℹ️ Click the thumbnail image above to view or download the high-resolution poster PDF.This poster, produced in collaboration with Akoya Biosciences, is presented at SITC 2022, Boston, USA. The aim of this study was to utilize Akoya’s multiplexed imaging technology and...
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach
OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022. The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio. The work involved multiplex...
Utilizing Quantitative Digital Pathology techniques for analysis of Hepatitis B liver samples stained with a 12-plex multiplex-IF assay
OracleBio data is presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York. The poster, produced in collaboration with Gilead, involved a comprehensive evaluation of Hepatitis B liver samples stained using a 12-plex assay, with this poster...
Find out more about our Multiplex IF Analysis
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more